PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 63 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

22 October 2024

  1. (diff | hist) N 09:00 Drug master file 1,551 +1,551 MissedDoseMik (talk | contribs) new article: drug regulation, expansion welcome
  2. (diff | hist) 08:53 GLP-1 receptor 4,864 ±0 HalfLifeHavel (talk | contribs) alphabetise the see-also list [rollback]
  3. (diff | hist) 08:29 Talk:Blind sampling 822 +136 ChainCustodyChad (talk | contribs) /* Is "almost no" defensible without a count? */ reply
  4. (diff | hist) m 07:21 Good manufacturing practice 2,472 +33 MTC_Marisol (talk | contribs) move a stray full stop inside the reference [rollback]
  5. (diff | hist) m 07:17 Limit of detection 2,589 ±0 NewLabNell (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  6. (diff | hist) 05:12 Peptide supply chain 2,638 +1,260 CDMO_Caradoc (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]
  7. (diff | hist) 05:07 Guangzhou JEEP Biotechnology 5,372 ±0 BlindSampleBrid (talk | contribs) add the catalogue size and label it self-reported [rollback]
  8. (diff | hist) m b 04:52 Wuhan Wansheng Biotechnology 6,279 +201 CiteBot (talk | contribs) bot: sort category members [rollback]
  9. (diff | hist) m b 04:08 International nonproprietary name 1,833 +727 CiteBot (talk | contribs) bot: add drug-class category [rollback]
  10. (diff | hist) 01:19 TRIUMPH trial programme 2,480 +524 FiveOhThreeA (talk | contribs) add the confidence interval to the point estimate [rollback]

21 October 2024

  1. (diff | hist) 20:17 ISO 9001 2,449 +32 Compounding_Cate (talk | contribs) clarify the difference between a marketing authorisation and a registration [rollback]
  2. (diff | hist) 18:19 Qingdao Sigma Chemical 4,478 +231 AnalyticalAnnie (talk | contribs) expand §External links [rollback]
  3. (diff | hist) 13:47 Talk:Blind sampling 611 +225 TallySheetTad (talk | contribs) /* Is "almost no" defensible without a count? */ reply
  4. (diff | hist) m b 12:41 PeptideMeter 2,760 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  5. (diff | hist) 09:12 Talk:Blind sampling 400 +169 BlindSampleBrid (talk | contribs) /* Is "almost no" defensible without a count? */ new section
  6. (diff | hist) 06:22 WuXi TIDES 5,922 +1,329 eGFR_Esme (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  7. (diff | hist) 05:29 Sterile water for injection 2,419 ±0 UnitAuditUwe (talk | contribs) the rounding in the table lost a decimal place that matters at low doses [rollback]
  8. (diff | hist) 00:26 GLP-1 receptor agonist 6,307 +187 LOD_Lorcan (talk | contribs) expand §Molecular strategies for half-life extension [rollback]

20 October 2024

  1. (diff | hist) 22:49 Trifluoroacetate counterion 2,370 ±0 AmylinAmos (talk | contribs) ce [rollback]
  2. (diff | hist) m 21:36 Chinese Peptide Company 4,517 +192 BlindSampleBrid (talk | contribs) state the city and province of the registered address [rollback]
  3. (diff | hist) 16:58 Custom peptide synthesis 2,407 +268 PrepHPLC_Pia (talk | contribs) unpipe a link that did not need piping [rollback]
  4. (diff | hist) m 16:23 Amylin 3,204 +639 IcodecIndra (talk | contribs) convert the substitution list to a table so the analogues line up [rollback]
  5. (diff | hist) m 16:16 Electrospray ionisation 2,185 +206 KarlFischerKit (talk | contribs) add the detection wavelength [rollback]
  6. (diff | hist) m 11:19 Nantong Guangyuan Chemical 5,877 +159 TallySheetTad (talk | contribs) expand §Ordering and availability [rollback]
  7. (diff | hist) m 08:42 Exenatide 1,991 +715 Retention_Time_Rae (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]
  8. (diff | hist) 04:22 Chain of custody 2,933 +260 VerifyVesna (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  9. (diff | hist) 00:57 Test report forgery 1,998 +676 VerifyFirstVida (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  10. (diff | hist) 00:12 Insulin secretion 3,940 +134 Chromatokid (talk | contribs) state that the receptor is a class B G-protein-coupled receptor [rollback]

19 October 2024

  1. (diff | hist) 10:37 Cold chain 11,453 +163 PeakShapePol (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  2. (diff | hist) m b 09:43 Retatrutide 3,907 +425 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 05:07 Reference standard 2,872 ±0 DeadSpaceDot (talk | contribs) expand §Use in identification [rollback]
  4. (diff | hist) m 04:11 USP General Chapter 85 2,086 +810 IsocraticIla (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  5. (diff | hist) 02:40 C-peptide 2,537 +31 ApoB_Aurelio (talk | contribs) add the units and the conversion factor to SI [rollback]
  6. (diff | hist) 01:50 Lixisenatide 1,771 ±0 AnalyticalAnnie (talk | contribs) convert the substitution list to a table so the analogues line up [rollback]

18 October 2024

  1. (diff | hist) N 23:41 CagriSema 1,661 +1,661 MergeMorwenna (talk | contribs) create article — compound stub
  2. (diff | hist) m 22:14 Lyophilisation 7,435 ±0 CoI_Corin (talk | contribs) split §Cold chain from §Storage after receipt [rollback]
  3. (diff | hist) 18:12 Peptide aggregation 2,241 ±0 LeaderLoic (talk | contribs) add the figure for the chromatogram and caption its axes [rollback]
  4. (diff | hist) 17:16 FLOW trial 1,950 ±0 TirzTaxonomist (talk | contribs) split the results table so the two doses are separate rows [rollback]
  5. (diff | hist) 11:43 Subcutaneous injection 2,986 +28 Chromatokid (talk | contribs) state the syringe graduation the unit figure assumes [rollback]
  6. (diff | hist) 10:24 Talk:Hunan Aslsen Technology 1,033 +106 VerifyVesna (talk | contribs) /* "Verified by" is not a test result */ reply
  7. (diff | hist) 09:36 Aspiration risk under anaesthesia 2,259 +1,029 MTC_Marisol (talk | contribs) clarify that the rodent finding has not been observed in humans [rollback]
  8. (diff | hist) N 09:00 Insulin syringe unit conversion 1,302 +1,302 DiffWatchDov (talk | contribs) new article: reference tool, expansion welcome
  9. (diff | hist) 05:28 Liraglutide 3,239 ±0 ColdChainCleo (talk | contribs) add short description [rollback]
  10. (diff | hist) 03:14 Area percent purity 3,346 +369 ResolutionRoo (talk | contribs) clarify that area percent is not mass percent [rollback]
  11. (diff | hist) 03:10 Cagrilintide 2,406 ±0 SchematicScout (talk | contribs) add the peptide length to the infobox [rollback]

17 October 2024

  1. (diff | hist) 22:53 Number needed to treat 1,750 +628 TriumphThad (talk | contribs) expand §Number needed to harm [rollback]
  2. (diff | hist) 18:18 Janoshik Analytical 2,971 ±0 BlankVialBo (talk | contribs) correct the description of the sampling procedure [rollback]
  3. (diff | hist) 17:27 Amylin receptor agonist 1,601 ±0 PrimarySrcPatia (talk | contribs) convert the substitution list to a table so the analogues line up [rollback]
  4. (diff | hist) 10:13 Missed dose 2,029 +597 Chromatokid (talk | contribs) add the preservative point: unpreserved diluent changes the interval [rollback]
  5. (diff | hist) m 05:04 Tirzepatide 4,843 +137 TelehealthTruus (talk | contribs) add the receptor targets to the lead sentence [rollback]
  6. (diff | hist) 03:25 Beyond-use date 3,225 +1,009 BUD_Bertram (talk | contribs) state that swirling rather than shaking is the handling convention, sourced [rollback]
  7. (diff | hist) m b 02:40 Bachem Holding (Suzhou) 2,103 +411 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  8. (diff | hist) N 00:41 Beyond-use date 2,216 +2,216 UnitAuditUwe (talk | contribs) new article: dosing and handling, expansion welcome

16 October 2024

  1. (diff | hist) m 23:41 Beta cell function 3,162 +416 HalfLifeHavel (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  2. (diff | hist) 23:12 High-performance liquid chromatography 4,166 +840 ResolutionRoo (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  3. (diff | hist) m 21:45 Triple agonist 2,043 ±0 BetaCellBoyd (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  4. (diff | hist) m 15:17 Albumin binding half-life extension 3,157 +336 AmylinAmos (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]
  5. (diff | hist) 11:38 Dual incretin agonist 3,352 +121 ParentCatPansy (talk | contribs) move a stray full stop inside the reference [rollback]
  6. (diff | hist) N 09:00 ChinaPeptides 1,693 +1,693 SVG_Solomon (talk | contribs) create organisation article per PP:VN
  7. (diff | hist) N 09:00 Cold-chain freight 1,900 +1,900 FreightFenna (talk | contribs) start article on the process step
  8. (diff | hist) m 08:17 SUSTAIN trial programme 3,660 +836 API_Aurora (talk | contribs) state the analysis population: intention-to-treat or per-protocol [rollback]
  9. (diff | hist) 08:12 Residual solvent 2,880 +918 TechnicianTeal (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  10. (diff | hist) 02:25 Dulaglutide 2,958 +1,048 GastroparesisGwen (talk | contribs) give the isoelectric point with the method it was determined by [rollback]
  11. (diff | hist) 00:37 List of GLP-1 receptor agonists 2,257 ±0 Chromatokid (talk | contribs) add the cross-link to the parent article [rollback]
  12. (diff | hist) 00:19 Third-party testing 4,411 +104 Peptide_Pete (talk | contribs) add the cost basis, since it shapes who submits [rollback]

15 October 2024

  1. (diff | hist) 19:52 Insulin syringe 2,790 +141 SubQ_Solveig (talk | contribs) add the diluent volume the example assumes [rollback]
  2. (diff | hist) m 13:35 Bacteriostatic water 2,807 ±0 DeadSpaceDot (talk | contribs) expand §Common misunderstandings [rollback]
  3. (diff | hist) m 11:53 Peptide supply chain 1,378 ±0 Ref_Desk_Ron (talk | contribs) rm a duplicated category [rollback]
  4. (diff | hist) 11:44 Talk:Nantong Guangyuan Chemical 1,244 +77 Ref_Desk_Ron (talk | contribs) /* Multiple trading names: which is the title? */ reply
  5. (diff | hist) 09:52 Talk:Hunan Aslsen Technology 822 +278 BlindSampleBrid (talk | contribs) /* "Verified by" is not a test result */ reply
  6. (diff | hist) 07:34 SELECT trial 2,782 +454 KPV_Kester (talk | contribs) split overlong sentence [rollback]
  7. (diff | hist) N 05:56 USP General Chapter 85 1,276 +1,276 SigFigSindri (talk | contribs) create article — method stub
  8. (diff | hist) 05:45 Placebo-adjusted effect 2,157 +881 DrTitration (talk | contribs) add the PMID [rollback]
  9. (diff | hist) 05:05 HOMA-IR 1,827 +237 PlainNumbersPip (talk | contribs) clarify that the reference interval is not a treatment target [rollback]
  10. (diff | hist) m 05:02 VendorInvestigate 2,824 +231 MissedDoseMik (talk | contribs) rm the ranking language; this wiki publishes no ranking [rollback]
  11. (diff | hist) m b 03:45 Glucose-dependent insulinotropic polypeptide 5,300 +266 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  12. (diff | hist) N 03:23 Aspiration risk under anaesthesia 1,230 +1,230 PreregPriya (talk | contribs) start article; incidence figures to follow

14 October 2024

  1. (diff | hist) 22:37 Adverse effects of GLP-1 receptor agonists 3,137 ±0 MassSpecMarv (talk | contribs) add the monitoring recommendation as attributed to the labelling [rollback]
  2. (diff | hist) 20:17 Glucagon 4,114 +428 SurvodutideSaff (talk | contribs) split overlong sentence [rollback]
  3. (diff | hist) 19:05 Liquid chromatography-mass spectrometry 2,132 ±0 AnalyticalAnnie (talk | contribs) split §Principle from §Practical limitations [rollback]
  4. (diff | hist) 18:31 Weight regain after discontinuation 2,792 +978 AnaesthesiaAoife (talk | contribs) state whether the figure is from a trial or from post-marketing reporting [rollback]
  5. (diff | hist) 18:04 Satiety signalling 3,234 +488 LabRangeLindy (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  6. (diff | hist) 14:08 Talk:Hunan Aslsen Technology 611 +237 NPOV_Nadia (talk | contribs) /* "Verified by" is not a test result */ reply
  7. (diff | hist) m b 12:44 Vial 11,177 +1,970 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  8. (diff | hist) 12:26 Retention time 2,283 +256 HypoHildur (talk | contribs) add category for method validation [rollback]
  9. (diff | hist) 11:31 Talk:Hunan Aslsen Technology 400 +410 VerifyVesna (talk | contribs) /* "Verified by" is not a test result */ new section
  10. (diff | hist) 09:24 Dose escalation schedule 1,918 ±0 A1c_Alder (talk | contribs) rm the individualised advice — the article describes, it does not instruct [rollback]
  11. (diff | hist) m 08:35 TRIUMPH trial programme 1,956 ±0 LeanMassLars (talk | contribs) add the trial acronym expansion at first use [rollback]
  12. (diff | hist) 07:22 Peptide synthesis 3,010 +91 SupplyWatchSuri (talk | contribs) expand §The elementary cycle [rollback]

13 October 2024

  1. (diff | hist) 21:29 Hunan Aslsen Technology 3,312 +696 Compounding_Cate (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]
  2. (diff | hist) 19:37 Glucagon-like peptide-1 7,399 +178 COA_Colwyn (talk | contribs) add the species in which the knockout work was done [rollback]
  3. (diff | hist) 16:04 Solid-phase peptide synthesis 3,349 +631 LedeLeander (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]
  4. (diff | hist) m 07:55 Karl Fischer titration 4,811 +330 Chromatokid (talk | contribs) expand §Chemical basis [rollback]
  5. (diff | hist) m b 04:01 GL Biochem (Shanghai) 6,908 ±0 ArchiveBot (talk | contribs) bot: mark outbound storefront link nofollow [rollback]
  6. (diff | hist) 02:34 Gastric emptying 3,153 ±0 LCellLeif (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]

12 October 2024

  1. (diff | hist) m 23:59 Research use only 3,726 +199 DMF_Dermot (talk | contribs) typo [rollback]
  2. (diff | hist) 23:14 Lot traceability 2,794 +126 IncretinIvo (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  3. (diff | hist) 21:29 Hypoglycaemia 2,490 ±0 ArchiveAudit (talk | contribs) rm the causal wording — spontaneous reports do not establish causation [rollback]
  4. (diff | hist) 19:23 Glossary of peptide terminology 3,438 +1,121 RfC_Rasmus (talk | contribs) correct the sort key so the entry files under its surname [rollback]
  5. (diff | hist) 16:31 Crude peptide 2,285 +415 CrudePeptidePearl (talk | contribs) attribute the stability figure to the study and its duration [rollback]